今开:132.5 | 昨收:138.01 |
最高:138.805 | 最低:124.08 |
涨停价:0.0 | 跌停价:0.0 |
总市值:4.9448008293E10 |
产业链观察03-06 06:29
#药闻简讯# 美国食品和药物管理局(FDA)批准了DexCom非处方Stelo产品,使其成为美国第一个获准无需处方即可使用的葡萄糖生物传感器,适用于未使用胰岛素治疗的 18 岁及以上人群.$德康医疗(DXCM)$查看全文
德康医疗(DXCM)03-12 06:35
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000034 Size: 5 KB 网页链接查看全文
德康医疗(DXCM)03-12 06:35
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000036 Size: 5 KB 网页链接查看全文
德康医疗(DXCM)03-12 06:35
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000035 Size: 5 KB 网页链接查看全文
德康医疗(DXCM)03-12 06:35
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000039 Size: 5 KB 网页链接查看全文
德康医疗(DXCM)03-15 05:45
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000048 Size: 5 KB 网页链接查看全文
德康医疗(DXCM)04-24 04:05
$德康医疗(DXCM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003163 Act: 33 Size: 8 KB 网页链接查看全文
产业链观察03-06 06:29
#药闻简讯# 美国食品和药物管理局(FDA)批准了DexCom非处方Stelo产品,使其成为美国第一个获准无需处方即可使用的葡萄糖生物传感器,适用于未使用胰岛素治疗的 18 岁及以上人群.$德康医疗(DXCM)$查看全文
8-K - Current report Filed: 2011-05-05 AccNo: 0001193125-11-127591 Size: 173 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits 网页链接
424B2 - Prospectus [Rule 424(b)(2)] Filed: 2011-05-05 AccNo: 0001193125-11-127594 Size: 388 KB 网页链接
8-K - Current report Filed: 2011-05-05 AccNo: 0001193125-11-127591 Size: 173 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits 网页链接
424B2 - Prospectus [Rule 424(b)(2)] Filed: 2011-05-05 AccNo: 0001193125-11-127594 Size: 388 KB 网页链接
FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2011-05-04 AccNo: 0001193125-11-126303 Size: 18 KB 网页链接
FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2011-05-04 AccNo: 0001193125-11-126303 Size: 18 KB 网页链接
S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers Filed: 2011-05-04 AccNo: 0001193125-11-126093 Size: 346 KB 网页链接
FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2011-05-04 AccNo: 0001193125-11-126303 Size: 18 KB 网页链接
$德康医疗(DXCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001093557-24-000079 Act: 34 Size: 7 MB 网页链接
$德康医疗(DXCM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001093557-24-000078 Act: 34 Size: 633 KB 网页链接
$德康医疗(DXCM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003163 Act: 33 Size: 8 KB 网页链接
$德康医疗(DXCM)$ DEF 14A Other definitive proxy statements Accession Number: 0001093557-24-000070 Act: 34 Size: 33 MB 网页链接
$德康医疗(DXCM)$ ARS Annual Report to Security Holders Accession Number: 0001093557-24-000071 Act: 34 Size: 2 MB 网页链接
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000064 Size: 5 KB 网页链接
$德康医疗(DXCM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003065 Act: 33 Size: 6 KB 网页链接
$德康医疗(DXCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001093557-24-000062 Size: 7 KB 网页链接
$德康医疗(DXCM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002974 Act: 33 Size: 7 KB 网页链接
$德康医疗(DXCM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002836 Act: 33 Size: 6 KB 网页链接